News

Nvidia (NASDAQ: NVDA) stock rose 0.3% and Hewlett Packard Enterprise (NYSE: HPE) rose 1.2% after the tech companies said they ...
Merck (MRK) stock is in focus as its Enflonsia RSV shot is cleared for infants in the U.S. in a market led by Sanofi (SNY) ...
On the currency front, sterling weakened as Bank of England easing bets rose following the release of the latest UK labor ...
With precious little to report out of Sino-U.S. trade talks in London, investors are ready to pounce on almost any sign a ...
From June 22-25, 160 leading minds will explore cutting-edge innovations and pressing issues shaping the future of health, medicine, and science. Spe ...
Merck’s shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.
The latest poll showed less than 30% of CEOs expected some sort of recession or slowdown over the next six months.
A major challenge that the FTSE 100 continues to face is the very weak levels of liquidity in stocks traded in London.
Ochre Bio, based in Oxford, has appointed Dr Elaine Sullivan as a senior independent non-executive director. Dr Sullivan said: "I look forward to supporting Ochre Bio’s development as the company ...
Background Prior work suggests different interstitial lung diseases (ILDs) that share the radiological usual interstitial pneumonia (UIP) pattern have an overall worse prognosis. However, ...